Head to Head Analysis: Health In Tech (NASDAQ:HIT) versus Marsh (NYSE:MRSH)

Health In Tech (NASDAQ:HIT) and Marsh (NYSE:MRSH) are both finance companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends and analyst recommendations.

Earnings and Valuation

This table compares Health In Tech and Marsh”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Health In Tech	$30.72 million	2.00	$1.71 million	$0.03	36.00
Marsh	$26.98 billion	3.11	$4.16 billion	$8.43	20.56

Marsh has higher revenue and earnings than Health In Tech. Marsh is trading at a lower price-to-earnings ratio than Health In Tech, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of current ratings for Health In Tech and Marsh, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health In Tech	1	0	0	1	2.50
Marsh	0	6	1	0	2.14

Health In Tech currently has a consensus price target of $2.50, suggesting a potential upside of 131.48%. Marsh has a consensus price target of $204.86, suggesting a potential upside of 18.22%. Given Health In Tech’s stronger consensus rating and higher probable upside, equities analysts clearly believe Health In Tech is more favorable than Marsh.

Institutional & Insider Ownership

88.0% of Marsh shares are held by institutional investors. 77.7% of Health In Tech shares are held by company insiders. Comparatively, 0.4% of Marsh shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares Health In Tech and Marsh’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Health In Tech	N/A	N/A	N/A
Marsh	15.42%	31.60%	8.26%

Volatility and Risk

Health In Tech has a beta of 8.56, meaning that its share price is 756% more volatile than the S&P 500. Comparatively, Marsh has a beta of 0.75, meaning that its share price is 25% less volatile than the S&P 500.

Summary

Marsh beats Health In Tech on 9 of the 15 factors compared between the two stocks.

About Health In Tech

Health in Tech, Inc. engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.

About Marsh

Marsh & McLennan Companies, Inc., a professional services company, provides advice and solutions to clients in the areas of risk, strategy, and people worldwide. It operates in two segments, Risk and Insurance Services, and Consulting. The Risk and Insurance Services segment offers risk management services, such as risk advice, risk transfer, and risk control and mitigation solutions, as well as insurance and reinsurance broking, catastrophe and financial modeling, and related advisory services; and insurance program management services. This segment serves businesses, public entities, insurance companies, associations, professional services organizations, and private clients. The Consulting segment provides health, wealth, and career consulting services and products; and specialized management, as well as economic and brand consulting services. Marsh & McLennan Companies, Inc. was founded in 1871 and is headquartered in New York, New York.